FindTrial
Sign In

EFFICACY OF TRANEXAMIC ACID IN REDUCING POSTPARTUM BLOOD LOSS FOLLOWING VAGINAL DELIVERY: A DOUBLE-BLIND PLACEBO CONTROLLED RANDOMIZED CLINICAL STUDY IN NAUTH, NNEWI

EFFICACY OF TRANEXAMIC ACID IN REDUCING POSTPARTUM BLOOD LOSS FOLLOWING VAGINAL DELIVERY: A DOUBLE-BLIND PLACEBO CONTROLLED RANDOMIZED CLINICAL STUDY IN NAUTH, NNEWI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202211791554683
Enrollment
110
Registered
2022-11-24
Start date
2022-12-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum blood loss

Interventions

Placebo Water for Injection
Tranexamic Acid

Sponsors

Nnaedozie Paul Obiegbu
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. 18years and above at time of consent 2. Singleton pregnancy 3. Term gestation ( = 37 completed weeks)

Exclusion criteria

Exclusion criteria: 1. Multiple pregnancy 2. History of eclampsia or pre-eclampsia in index pregnancy 3. Imminent delivery (<2 hours) from presentation 4. History of bleeding disorders 5. History of allergy to tranexamic acid

Design outcomes

Primary

MeasureTime frame
Primary outcome measures will be the mean postpartum blood loss following vaginal delivery and haemoglobin change—

Secondary

MeasureTime frame
Need for blood transfusion in the postpartum period;Need for additional uterotonics;Need for other surgical interventions for postpartum haemorrhage (such as B-lynch procedure, bilateral uterine artery ligation or hysterectomy)—

Countries

Nigeria

Contacts

Public ContactAdaeze Obiegbu

Resident Doctor

omalichaada1@gmail.com+2347067014836

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026